Home / MET Knockout Cell Lines

MET Knockout Cell Lines

Gene: MET

Official Full Name: MET proto-oncogene, receptor tyrosine kinaseprovided by HGNC

Gene Summary: This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00996 MET Knockout cell line (A549) Human MET 1:3~1:4 Negative Online Inquiry
KO01400 MET Knockout cell line (HeLa) Human MET 1:3~1:6 Negative Online Inquiry
KO10609 MET Knockout cell line (HCT 116) Human MET 1:2~1:4 Negative Online Inquiry
KO10610 MET Knockout cell line (HEK293) Human MET 1:3~1:6 Negative Online Inquiry

Background

MET Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the function of the MET gene, which encodes the hepatocyte growth factor receptor (c-MET). This receptor plays a critical role in various cellular processes, including proliferation, survival, and migration, making it a significant factor in cancer metastasis, tissue regeneration, and development. The MET Gene Knockout Cell Lines allow researchers to investigate the specific contributions of c-MET signaling pathways by providing a controlled environment devoid of MET expression, facilitating insights into its biological relevance and therapeutic potential.

These cell lines utilize CRISPR/Cas9 gene editing technology to induce precise deletions or mutations within the MET gene, thereby disrupting its normal function. This mechanism of action enables researchers to dissect downstream effects on cell signaling and phenotype, making it an invaluable tool for understanding disease mechanisms, particularly in oncology, where aberrant MET signaling is associated with tumorigenesis and metastasis. Furthermore, applications extend to drug discovery, particularly when exploring targeted therapies aimed at inhibiting c-MET activity.

Compared to other gene knockout systems, MET Gene Knockout Cell Lines offer higher specificity and efficiency due to their bespoke engineering. They minimize off-target effects and provide reproducible results, which are often a concern with traditional knockout techniques. Additionally, our cell lines come with comprehensive documentation on genotyping, validation, and suggested methodologies, facilitating a seamless integration into existing research workflows.

For researchers and clinicians, these cell lines represent not just a research tool but a gateway to advancing understanding in cancer biology and therapeutic interventions. Their role in elucidating c-MET’s contribution to disease processes makes them indispensable for those seeking to innovate in the fields of molecular biology and pharmacology. Our company's expertise in genetic engineering and commitment to quality assurance ensure that our MET Gene Knockout Cell Lines are reliably produced, allowing users to focus on scientific breakthroughs without compromise.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.